Jung-Kyun Kim
Private Equity Investor at Nau IB Capital Co. Ltd. (Venture Capital)
Profile
Jung-Kyun Kim is currently the Managing Director at Nau IB Capital Co. Ltd., a venture capital firm.
Prior to this, he was the Chief Executive Officer at Boryung Holdings Co., Ltd.
Mr. Kim completed his undergraduate degree at Korea Aerospace University.
Jung-Kyun Kim active positions
| Companies | Position | Start |
|---|---|---|
Nau IB Capital Co. Ltd. (Venture Capital)
 Nau IB Capital Co. Ltd. (Venture Capital) Investment ManagersFinance Nau IB Capital Co. Ltd. (Venture Capital) (Nau IB) is a venture capital subsidiary of Nau IB Capital founded by Seung-Won Lee in 2003. The firm is headquartered in Seoul, Korea. | Private Equity Investor | - |
Former positions of Jung-Kyun Kim
| Companies | Position | End |
|---|---|---|
Boryung Holdings Co., Ltd.
 Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | Chief Executive Officer | - |
Training of Jung-Kyun Kim
| Korea Aerospace University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Nau IB Capital Co. Ltd. (Venture Capital)
Nau IB Capital Co. Ltd. (Venture Capital) Investment ManagersFinance Nau IB Capital Co. Ltd. (Venture Capital) (Nau IB) is a venture capital subsidiary of Nau IB Capital founded by Seung-Won Lee in 2003. The firm is headquartered in Seoul, Korea. | Finance |
Boryung Holdings Co., Ltd.
Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | Health Technology |
- Stock Market
- Insiders
- Jung-Kyun Kim
